ORCID as entered in ROS

Select Publications
2010, 'Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, NORWAY, Oslo, pp. 11 - 11, presented at 21st Meeting of the European-Association-for-Cancer-Research, NORWAY, Oslo, 26 June 2010 - 29 June 2010, http://dx.doi.org/10.1016/S1359-6349(10)70852-1
,2005, 'Recurrent HUS following kidney transplant possibly precipitated by CMV', in IMMUNOLOGY AND CELL BIOLOGY, BLACKWELL PUBLISHING, AUSTRALIA, Canberra, pp. A16 - A17, presented at 23rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, AUSTRALIA, Canberra, 11 May 2005 - 13 May 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230636500066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,(ed.), 2016, 'Empowering Online Learners Using Assessment and Feedback', UNSW, presented at Towards 2025: Inspiring Learning, UNSW, 31 October 2016 - 31 October 2016
,2016, 'Student Engagement in the Personalised Medicine MOOC: Does the Learning Platform Matter?', presented at UNSW Medicine Learning and Teaching Forum, UNSW, Sydney, 07 December 2016 - 07 December 2016
,2016, 'The Hope and Hype of the Genetic Revolution: Reflections on UNSW Medicine's First MOOC', presented at Connections Seminar Series, UNSW Australia, UNSW Australia, 19 May 2016 - 19 May 2016
,2015, 'Hope and Hype: Reflections on UNSW Medicine's First MOOC', presented at 2015 UNSW Medicine Learning and Teaching Forum, UNSW, Sydney, NSW, Australia, 02 December 2015 - 02 December 2015, https://med.unsw.edu.au/annual-learning-and-teaching-forum
,2014, 'Reflections on the development of an open online course', presented at UNSW Medicine Learning and Teaching Forum 2014, UNSW Australia, 10 December 2014 - 10 December 2014, http://med.unsw.edu.au/annual-learning-and-teaching-forum
,2014, 'Hear the Ror! The role of Wnt signalling in ovarian cancer.', presented at International Society for Gynecologic Cancers, Melbourne, 08 November 2014 - 11 April 2015
,2014, 'HEAR THE ROR! THE ROLE OF WNT SIGNALLING IN OVARIAN CANCER'
,2024, 'ROR1 MRNA EXPRESSION IN GLIOMA - A NOVEL PROGNOSTIC BIOMARKER', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, ENGLAND, Cambridge, Vol. 26, presented at Annual Conference of the British-Neuro-Oncology-Society (BNOS), ENGLAND, Cambridge, 17 July 2024 - 19 July 2024, http://dx.doi.org/10.1093/neuonc/noae158.016
,2023, 'Patient-derived organoid models for drug screening in molecular subtypes of endometrial cancer', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 30, presented at AACR Special Conference on Endometrial Cancer - Transforming Care through Science, MA, Boston, 16 November 2023 - 18 November 2023, http://dx.doi.org/10.1158/1557-3265.ENDO24-B014
,2023, 'DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: A meta-analysis and systematic review', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 84, presented at AACR Special Conference on Ovarian Cancer, MA, Boston, 05 October 2023 - 07 October 2023, http://dx.doi.org/10.1158/1538-7445.OVARIAN23-A115
,2020, 'ROR2 is epigenetically regulated in endometrial cancer', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 27, presented at AACR Special Conference on Endometrial Cancer - New Biology Driving Research and Treatment, ELECTR NETWORK, 09 November 2020 - 10 November 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000617951200068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Deciphering the origin of circulating cell-free DNA and its alterations during menstruation', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 80, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020, http://dx.doi.org/10.1158/1538-7445.AM2020-731
,2020, 'ROR1: A novel target in endometrial cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 80, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020, http://dx.doi.org/10.1158/1538-7445.AM2020-2942
,2019, 'ROR1 is associated with ovarian cancer progression and chemoresistance.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 26, pp. 59 - 60, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000546013300077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, Brace yourself genetic testing might give you more than you bargained for., https://theconversation.com/brace-yourself-genetic-testing-might-give-you-more-than-you-bargained-for-40246
,2024, A novel approach for the quantification of single-cell adhesion dynamics from microscopy images, http://dx.doi.org/10.1101/2024.10.08.616409
,2024, Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer, http://dx.doi.org/10.1101/2024.03.09.24303840
,2024, Development and validation of a computational tool to predict treatment outcomes in cells from High-Grade Serous Ovarian Cancer patients, http://dx.doi.org/10.1101/2024.10.02.616212
,2023, Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer, http://dx.doi.org/10.22541/au.169580899.90269470/v1
,2023, Accurate identification of cancer cells in complex pre-clinical models using deep-learning: a transfection-free approach, http://dx.doi.org/10.1101/2023.10.15.562411
,2023, DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: a meta-analysis and systematic review, http://dx.doi.org/10.1101/2023.05.24.23290442
,2023, Model Parameter identification using 2D vs 3D experimental data: a comparative analysis, http://dx.doi.org/10.1101/2023.05.17.541071
,2021, Pan-tissue and -cancer analysis of ROR1 and ROR2 transcript variants identify novel functional significance for an alternative splice variant of ROR1, http://dx.doi.org/10.1101/2021.11.24.469652
,2021, ROR1 is a novel putative druggable target for diffuse glioma, http://dx.doi.org/10.1101/2021.12.03.21267166
,